2  Yatabe N, Kyo S, Maida Y, et al. HIF-1-mediated activation of telomerase in cervical cancer cells. Oncogene, 2004，23(20):3708-3715.

    3  Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature,1998,396(6712):643-649.

    4  Koshiji M, To KK, Hammer S, et al. HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression. Mol Cell, 2005,17(6):793-803.

    5  Yang J, Chen Z, Liu Y, et al. Altered DNA polymerase iota expression in breast cancer cells leads to reduction in DNA replication fidelity and a higher rate of muytagenesis  . Cancer Res, 2004，64(16):5597-5607.

    6  Ito A, Koshikawa N, Mochizuki S, et al. Hypoxia-inducible factor-1 mediates the expression of DNA polymerase iota in human tumor cells. Biochem Biophys Res Commun, 2006,351(1):306-311.

    7  Kelly BD, Hackett SF, Hirota K, et al. Cell type-specific regulation of angiogenic growth factor gene expression in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res, 2003，93(11):1074-1081.

    8  Ravi R, Mookerjee B, Bhujwalla ZM, et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev, 2000,14(1):34-44.

    9  Stoeltzing O, McCarty MF, Wey JS, et al. Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation. J Natl Cancer Inst,2004,96(12):946-956.

    10  Tang N, Wang L, Esko J, et al. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell, 2004,6(5):485-495.

    11  Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis. Nat Rev Cancer, 2004,4(11):891-899.

    12  Iyer NV, Kotch LE, Agani F, et al.Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev, 1998，12(2):149-162.

    13  Robey IF, Lien AD, Welsh SJ, et al.Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors. Neoplasia, 2005，7(4):324-330.

    14  Cramer T, Yamanishi Y, Clausen BE, et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell, 112(5):645-657.

    15  Feldser D, Agani F, Iyer NV, et al. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res，1999，59(16):3915-3918.

    16  Fukuda R, Hirota K, Fan F, et al. Insulin like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem, 2002，277(41):38205-38211.

    17  Gunaratnam L, Morley M, Franovic A, et al. Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory oathway in VHL(-/-) renal carcinoma cells. J Biol Chem, 2003，278(45):44966-44974.

    18  Krishnamachary B, Berg-Dixon S, Kelly B, et al. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res, 2003，63(5):1138-1143.

    19  McMahon S, Grondin F, McDonald PP, et al. Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1: impact on the bioactivation of proproteins. J Biol Chem, 2005，280(8):6561-6569.

    20  Petrella BL, Lohi J, Brinckerhoff CE. Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma. Oncogene, 2005，24(6):1043-1052.

    21  Raval RR, Lau KW, Tran MG, et al. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von HippelLindau-associated renal cell carcinoma. Mol Cell Biol, 2005，25:5675-5686.

    22  Niizeki H, Kobayashi M, Horiuchi I, et al. Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells. Br J Cancer, 2002，86(12):1914-1919.

    23  Pennacchietti S, Michieli P, Galuzzo M, et al. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell， 2003，3(4):347-361.

    24  Schioppa T, Uranchimeg B, Saccani A, et al.Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med, 2003,198(9):1391-1402.

    25  Staller P, Sulitkova J, Lisztwan J, et al. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature, 2003,425(6955):307-311.

    26  Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature, 2001,410(6824):50-56.

    27  Aebersold DM, Burri P, Beer KT, et al. Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res, 2001,61(7):2911-2916.

    28  Unruh A, Ressel A, Mohamed HG, et al. The hypoxia-inducible factor-1α is a negative factor for tumor therapy. Oncogene, 2003,22(21):3213-3220.

    29  Williams KJ, Telfer BA, Xenaki D, et al. Enhanced response to radiotherapy in tumors deficient in the function of hypoxia-inducible factor-1. Radiother Oncol, 2005,75(1):89-98.

    30  Moeller BJ, Cao Y, Li CY, et al. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygen, free radicals, and stress granules. Cancer Cell, 2004,5(5):429-441.

    31  Comerford KM, Wallace TJ, Karhausen J, et al. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res, 2002,62(12):3387-3394.

    32  Krishnamurthy P, Ross DD, Nakanishi T, et al. The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J Biol Chem, 2004，279(23):24218-24225.